 (Gut 1999;44:353-360) 
Several enteric neurotransmitters and gut hormones-for example, acetylcholine, 5-hydroxytryptamine, substance P, and neurotensin-inhibit electrically silent Na + absorption via a Ca 2+ dependent mechanism, but the physiological role of this system is not known. 1 2 One possible function may be down regulation of epithelial transport activity in the fasting state. When the "feeding programme" is activated, ileal Na + absorption increases significantly, 3 and this response is blocked by high dose amiloride, suggesting disinhibition of villus Na + /H + exchanger (NHE) activity. The absorbing enterocytes may consequently alternate between a "resting" and an active state, depending on the degree of inhibitory neural activity.
While studying the linkage between interdigestive motility and secretion in the upper small intestine in humans, 4 we made the observation that atropine tended to enhance duodenal HCO 3 − absorption. In the proximal small intestine, bicarbonate is absorbed by Na + /H + exchange 5 6 -that is, with an excess of in the lumen, NHE activity will be rate limiting for active HCO 3 − absorption (fig 1) . If cholinergic neurones tonically inhibit NHE activity in the fasting state, one will consequently expect blockade of this inhibitory influence to enhance active HCO 3 − absorption. This eVect also actually occurs when atropine is given intravenously to anaesthetised rats. 8 In the experiments described below, we used HCO 3 − absorption as an indirect marker for vectorial NHE activity, and tried to test the hypothesis that, in the fasting state, this activity is tonically inhibited by a cholinergic atropine sensitive mechanism. Using a modified triple Abbreviations used in this paper: MMC, migrating motor complex; NHE, Na + /H + exchanger; PEG, polyethylene glycol. 3 − absorption in proximal small intestine. The unstirred layer of the villi is constantly acidified 7 by Na + /H + exchanger (NHE) activity in the apical membrane of the enterocytes. HCO 3 − ions from the alkaline luminal compartment react with protons in the unstirred layer, and the CO 2 formed in this reaction is rapidly absorbed by the mucosa. This system for HCO 3 − absorption has a very high capacity and is hard to saturate. 6 The rate of proton formation will influence the apparent aYnity for HCO 3 − -that is, an increased NHE activity will enhance absorption at a given luminal HCO 3 − concentration.
Figure 1 A model illustrating the mechanism for active HCO

Alkaline luminal phase
Acidic unstirred layer lumen perfusion technique, we measured distal duodenal HCO 3 − absorption in healthy human volunteers under control conditions and after atropine administration. To obtain some additional information about the mechanisms behind the atropine response, we also included a small group of patients with villus atrophy in the study. Motor activity markedly influences HCO 3 − absorption in the mixing segment, 9 and to minimise the impact of this factor, the atropine data were compared with periods of similar but "spontaneous" motor quiescence, for which purpose we used the first 30 minutes of the interdigestive motility cycle.
Materials and methods
Thirty four healthy volunteers and eight patients with villus atrophy participated in the study. The healthy volunteers had no history of gastrointestinal disease and were free from medication. The protocol was approved by the ethical committee at Sahlgrenska University Hospital, Göteborg, and all participants had given informed consent. The patients were informed about the scientific nature of the study, and they all participated voluntarily. The study was part of a diagnostic "work up" for patients with suspected coeliac disease, and the patients had agreed to refrain from changes in diet until all diagnostic procedures were completed. The diagnosis of villus atrophy was based on duodenal biopsies in triplicate showing signs of subtotal or total villus atrophy, crypt hyperplasia, and increased numbers of inflammatory cells in the lamina propria. The mean age of the volunteers was 25 (range 20-39) years and the mean age of the villus atrophy patients was 39 (range 20-53) years. The experiments started with the intubation procedure at 7 30 am, and continued for about four hours.
TRIPLE LUMEN PERFUSION TECHNIQUE
This technique has been described in detail in several previous publications to which the reader is referred for technical details. 4 10 11 The subjects were intubated with a specially constructed four-or five-lumen nasogastric tube (modified Salem no 12 French, Argyle, Belgium). The tube, which contained one infusion channel, two aspiration channels, and one or two pressure channels, was placed with its tip at the duodenojejunal flexure, with the aid of intermittent fluoroscopy. An isotonic Krebs/ mannitol solution with a bicarbonate concentration of 25 mmol/l (for composition, see below) was infused just distal to the papilla Vateri at a rate of about 6 ml/min, the exact pump rate being calibrated in each experiment. During the early part of the migrating motor complex (MMC) cycle, this solution generates a slightly lumen positive transmural potential diVerence 4 11 and a luminal HCO 3 − concentration of about 20 mmol/l (or lower) at the entry to the test segment-that is, HCO 3 − absorption occurs against an electrochemical gradient (active absorption). In some experiments, the duodenum was instead perfused with saline, to measure secretory HCO 3 − fluxes. Both solutions contained polyethylene glycol (PEG, molecular mass 4000 Da) at a concentration of 2 g/l, as a non-absorbable volume marker. 12 The luminal contents were aspirated at two distal sites, 5 cm (proximal aspiration site) and 15 cm (distal aspiration site) distal to the infusion site-that is, in the mid duodenum and at the level of the duodenojejunal flexure respectively. The 5 cm segment between the infusion point and the proximal aspiration point acted as mixing segment, and the subsequent 10 cm segment was our test segment. After a run for a period of 40 minutes, fluid was aspirated manually at a rate of 0.7 ml/min from the proximal and distal aspiration sites. The distal aspiration started five minutes after the proximal aspiration, to compensate for estimated mean transit time through the test segment. 13 In most experiments, aspirates were collected at 15 minute intervals, and mean values from two 15 minute aspiration periods were used as 30 minute data. In some experiments (mainly the villus atrophy group), fluid was instead collected in 30 , where S, the solubility constant for CO 2 , has a value of 0.23 mmol/kPa per litre at 37°C 15 and the value for pK a , the first dissociation constant of carbonic acid in a plasma-like solution, is 6.10. 
RECORDING OF DUODENAL MOTOR ACTIVITY
A modified Arndorfer system was used to record duodenal motility. 17 Motor activity was always recorded 2 cm distal to the infusion site-that is, in the descending duodenum distal to the papilla Vateri, and in most experiments also at the duodenojejunal flexure, to confirm propagation of the activity front (phase III) of the MMC. The thin polyethylene catheters used for pressure recording were perfused with isotonic saline via narrow capillaries at a rate of 0.3 ml/min, and inflow pressure was recorded by pressure transducers connected to bridge amplifiers on a Grass polygraph (model 7D; Grass Instruments, Quincy, Massachusetts, USA). A contraction was defined as a phasic increase in intraluminal pressure exceeding 8 mm Hg. The frequency of contractions was calculated manually from the paper recordings every minute.
CONTROL PERIODS AND CORRECTIONS FOR EFFECTS OF ATROPINE ON MOTOR ACTIVITY
As atropine reduces motor activity, 4 we compared periods of "spontaneous" motor quiescence in the other groups (controls, NaCl, villus atrophy) with the atropine data. This was achieved by measuring during the first 30 minutes after phase III of the MMC. Phase III of the MMC cycle was defined as a period of motor activity at slow wave frequency (10-12 contractions/min) with a duration of at least two minutes. 18 If pressure was recorded at two sites, propagation of the front was also included in the definition of phase III activity.
EXPERIMENTAL GROUPS
The control group (n = 11) consisted of healthy volunteers, perfused with Krebs/ mannitol and receiving no experimental intervention. The saline group (n = 10) were also healthy volunteers perfused with saline and receiving no experimental intervention. The atropine group (n = 13) were healthy volunteers perfused with Krebs/mannitol and receiving atropine. Atropine (Kabi Vitrum AB, Stockholm, Sweden; 0.5 mg/ml) was given intravenously at a dose of 0.01 mg/kg 30-45 minutes after a phase III period, and this dose was followed by two additional injections at 30 minute intervals (0.1 mg each). 4 The "atropine" data were mean values obtained during the 90 minutes after atropine injection. The villus atrophy group (n = 8) consisted of patients with villus atrophy due to untreated coeliac disease; they were perfused with Krebs/ mannitol and received no experimental intervention.
INTESTINAL PERFUSATES
In most experiments the intestine was perfused with a Krebs/mannitol solution with the following composition (in mmol/l): 122 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 25 NaHCO 3 , 1.2 MgCl 2 and 30 mannitol (all from Sigma Chemicals, St Louis, Missouri, USA). The solution also contained PEG at a concentration of 2 g/l. The pH of the solution was approximately 8.0 (7.4 after equilibration with 5% CO 2 ) and the osmolality approximately 310 mosmol/kg. In the saline group, we perfused the intestine with physiological saline (NaCl 154 mmol/l), to which was added PEG 2 g/l. Krebs/mannitol was used as perfusate in the villus atrophy group.
CALCULATIONS AND STATISTICAL EVALUATION
In an unsaturated system, HCO 3 − absorption will be concentration dependent. Luminal HCO 3 − concentration at the proximal aspiration site was significantly lower in the atropine group and therefore the concentration factor had to be corrected for when comparisons of absolute HCO 3 − absorption rates in the diVerent groups were made. In the atropine group, most of the data followed a concentrationabsorption line that was roughly parallel to the control line. To test if the distribution of these data diVered from the control distribution, concentration values were fed into the equation for the control line, and calculated ("expected") HCO 3 − absorption values were compared with actual (measured) values, under the null hypothesis that the two sets of data belong to the same population. The same calculation was performed for the control group, and the significance of the diVerence between the two populations was then tested with the nonparametric Mann-Whitney U test.
In the villus atrophy group, there was no consistent relationship at all between HCO 3 − concentration and absorption, and therefore this "mathematical" approach was considered inappropriate. However, in this group, spontaneous luminal HCO 3 − concentration was not significantly diVerent from that obtained in the control group, and therefore this luminal concentration value (≈ 20 mmol/l) was chosen as the normalisation point for all three groups. At this concentration point, we were thus able to use actual measured data from controls and villus atrophy patients, and only had to normalise the atropine data to a concentration of 20 mmol/l, as calculated from the slope of the regression line. In this way, we were able to make a meaningful quantitative comparison of absolute HCO 3 − absorption rate in the three groups, at a similar luminal HCO 3 − concentration value.
The comparison between the three groups was performed with the non-parametric Kruskal-Wallis test and the Mann-Whitney U test. In the analysis of pH and PCO 2 data, we calculated PCO 2 and H + concentration at the proximal and distal aspiration sites. The diVerence between the two aspiration sites, within each group, was tested by the non-parametric Wilcoxon test, and the diVerence between absolute values at each aspiration site between the three groups was first tested with the Kruskal-Wallis test followed, if justified, by the non-parametric Mann-Whitney U test for independent samples. p<0.05 was regarded as statistically significant.
Results
There was no significant diVerence in motor activity between the groups (table 1). Luminal HCO 3 − concentration at the entry to the test segment was not significantly diVerent in the control and villus atrophy groups (≈ 20 mmol/ l), but was about 20% lower in the atropine group (15.2 (0.9) mmol/l; p<0.01 versus control and villus atrophy groups; results are mean (SE)). − concentration and HCO 3 − absorption (r = 0.32, p = 0.28). However, 10 of 13 subjects (solid squares) followed a regression line that was approximately parallel to the one obtained in the controls (which is indicated by the dashed line in fig 3) . The three remaining subjects (open squares) closely followed the control regression line. To test if the displacement of the atropine data from the control regression line was statistically significant, we fitted the concentration data in the atropine group into the control regression equation, and then compared measured and expected HCO 3 − absorption rate under the null hypothesis that the atropine data were randomly distributed around the control line. This calculation showed that the atropine data were significantly displaced to the left of the control population (control distribution: 0.0 (3.6); atropine distribution: +13.8 (3.7) µmol/min per 10 cm; p<0.05).
In the villus atrophy patients, there was no consistent relation at all between luminal HCO 3 − concentration and absorption (r = 0.075, p = 0.85; data not shown), and therefore this mode of recalculation was not considered appropriate for this group. However, luminal HCO 3 − concentration at the proximal aspiration site in the villus atrophy patients was not significantly diVerent from that in the control group (19.8 (1.1) v 21.4 (1.4) mmol/l). To be able to directly compare absolute HCO 3 − absorption values in all three groups at a similar luminal HCO 3 − concentration, we therefore used actual measured data from the control and villus atrophy groups and mathematically normalised the atropine data to the same luminal concentration (20 mmol/l), from the slope of the (control and atropine) regression lines. Figure 4 shows the results of this calculation. In the control group, the normalised HCO 3 − absorption rate was 35.4 (3.8) µmol/min per 10 cm, which increased to 48.0 (3.4) µmol/min per 10 cm after atropine administration (p<0.05 v control data). In the villus atrophy group, the normalised HCO 3 − absorption rate was 15. To analyse further the mechanism behind the apparent stimulatory eVect of atropine on HCO 3 − absorption, we also calculated luminal H + ion concentration and luminal PCO 2 values at the proximal and distal aspiration sites. Figure 5 summarises the results. At the proximal aspiration site, there was no significant diVerence in luminal H + ion concentration between the three groups (Kruskal-Wallis test, p = 0.09) ( fig 5A) . Between proximal and distal aspiration sites, H + concentration increased significantly in the atropine group (p<0.01) but no significant change occurred in the control group (p = 0.09) or in the villus atrophy group (p = 0.48). Consequently, at the distal aspiration site, luminal H + concentration in the atropine group was significantly higher and in the villus atrophy group significantly lower than in the control group (p<0.01).
Figure 5B summarises in a similar fashion luminal PCO 2 values at the proximal and distal aspiration sites. Luminal PCO 2 did not diVer between the groups, either at the proximal or distal aspiration sites, and no significant change in PCO 2 between proximal and distal aspiration sites occurred in any of the three groups.
Discussion
Atropine had three major eVects on duodenal HCO 3 − transport: it reduced luminal HCO 3 − concentration at the proximal aspiration site, it displaced the relation between HCO 3 − concentration and absorption to the left, and it induced significant acidification of the luminal contents at the distal aspiration site. Net absorption of a compound is the diVerence between the absorptive and secretory flux, and stimulation of net absorption may therefore be due to stimulation of the absorptive flux, inhibition of the secretory flux, or a combination of the two.
Atropine inhibits the secretory HCO 3 − flux in both the human proximal duodenum 19 and rat jejunum, 20 and this mechanism may therefore account for our findings. Theoretically, inhibition of a (normally reabsorbed) secretory HCO 3 − flux with a magnitude of about 20 µmol/min per 10 cm may account for the apparent leftward displacement of the atropine curve (fig 3) . Inhibition of a secretory flux with a relatively high HCO 3 − concentration may also account for the reduction in HCO 3 − concentration at the proximal aspiration site in the atropine group. The same mechanism would also reduce HCO 3 − concentration at the distal end of the test segment which, at a constant PCO 2 , would lead to an increase in luminal acidity. Inhibition of a secretory HCO 3 − flux is therefore an altogether possible explanation for our findings.
There are, however, some observations that are diYcult to reconcile with this interpretation. First, the secretory HCO 3 − flux may be very small at the level of our test segment-that is, even total inhibition of this flux may not suffice to account for the displacement of the saturation curve in the atropine experiments. Isenberg et al 21 have directly compared the secretory HCO 3 − flux in proximal and mid duodenum in humans and saw a 90% reduction from the bulb to the level of our mixing segment, which had a HCO 3 − secretion rate of only 3-4 µmol/min per 10 cm. It is always difficult to interpret segmental diVerences between species, but data from rat jejunum suggest that the basal secretory HCO 3 − flux is even lower more distally. 20 In the present study, we also tried to measure the secretory HCO 3 − flux by saline perfusion. HCO 3 − inflow into the mixing segment was 11.2 (6.0) µmol/min, which generated a luminal HCO 3 − concentration of 1.6 (0.8) mmol/l. However, despite this very low HCO 3 − concentration, net HCO 3 − transport in the test segment was not significantly diVerent from zero ( fig 2) . If a secretory flux of any quantitative magnitude had occurred at this level, it must consequently have been totally reabsorbed. In a saturated system, a reduced intrinsic substrate load will increase uptake of an extrinsic marker-that is, inhibition of a substantial HCO 3 − secretion by the mucosa itself will be expected to enhance HCO 3 − uptake from the lumen. However, the system was not saturated, as seen from the strong concentration dependence of HCO 3 − absorption. It is therefore very diYcult to envisage how inhibition of a minor secretory flux can account for the leftward displacement of the HCO 3 − absorption curve. A characteristic feature of HCO 3 − absorption is that it is very hard to saturate. In the The linear part of their saturation curve was virtually identical with our own, strongly suggesting that they were studying the same transport mechanism. An important question is whether this saturation curve fully accounts for the HCO 3 − concentration decrease between the infusion site and the proximal site, or if a secretory HCO 3 − flux has to be included to account for the observed concentration changes. To test this, we used the intercept of the regression line with the HCO 3 − concentration of our perfusate (25 mmol/l) to estimate HCO 3 − absorption in the mixing segment. The expected mean absorption rate (fig 2) will be 47/2 = 23.5 µmol/min. Mean flow rate through the mixing segment (including the pressure infusion) was 6.26 (0.19) ml/min and there was no significant net water flux (0.00 (0.15) ml/min). One consequently expects a mean luminal HCO 3 − concentration at the proximal aspiration site of 25 − (23.5/6.26) = 21.2 mmol/l, which agrees almost exactly with the measured mean value (21.4 (1.4) mmol/l, table 1). The most likely explanation for the relatively pronounced scatter around this mean value is interindividual diVerences in the degree of stirring motor activity in the mixing segment, which probably increases HCO 3 − uptake by improving the contact with the absorbing epithelium. 9 At least as judged from these rough calculations, HCO 3 − absorption thus seems to account fully for the HCO 3 − concentration changes at the proximal aspiration site.
A similar mode of calculation can also be used to estimate HCO 3 − inflow into the mixing segment. At the proximal aspiration site, the mean HCO 3 − "flow rate" (volume flow × [HCO 3 − ]) was 134 µmol/min. If the mixing segment had a similar absorption rate to the test segment-that is, 20-25 µmol/min per 5 cm, one would expect an initial mean HCO 3 − inflow rate of 155-160 µmol/min. HCO 3 − was infused at a rate of about 150 µmol/min-that is, only 5-10 µmol/min remain as a possible mean value for the secretory inflow into the mixing segment. Even this value, which agrees reasonably well with both Isenberg´s data 21 and our own NaCl experiments (our mean value was 11.2 (6.0) µmol/min), is probably an overestimation, as this mode of calculation assumes optimal stirring conditions in the mixing segment.
In the atropine group, 10 of 13 subjects followed a regression line that was displaced about 20 µmol/min per 10 cm to the left-that is, at a given concentration, HCO 3 − absorption was 20 µmol/min per 10 cm higher. The equation for this regression line gave an expected HCO 3 − absorption in the mixing segment of around 35 µmol/min which, with the mode of calculation used above, should lead to a further decrease in mean proximal HCO 3 − concentration value by about 3.5 mmol/l. The actually measured mean diVerence between controls and atropine data was 5 mmol/l (table 1) . Furthermore, the three experiments in the atropine group which seemed to follow the control regression line (solid squares in fig 3) also had a proximal HCO 3 − concentration which was virtually identical with the mean value in the control group. Attempts to estimate the amount of HCO 3 − entering the mixing segment in the atropine group gave negative values (−12.9 (6.6) µmol/min)-that is, in the atropine group, HCO 3 − absorption capacity in the mixing segment was probably even higher than in the test segment.
To conclude these numeric excursions, our data are theoretically compatible with both inhibition of HCO 3 − secretion and stimulation of HCO 3 − absorption, but increased aYnity of the absorptive mechanism accounts for both transport and concentration data in a strikingly consistent manner.
To obtain additional information on the transport mechanisms responsible for HCO 3 − absorption, we also included a small group of patients with villus atrophy in the study. The idea was that, if HCO 3 − absorption depends on NHE activity in the apical membrane of villus enterocytes, one would expect villus atrophy to have the opposite eVect to atropine-that is, to reduce HCO 3 − absorption and to decrease H + and CO 2 formation. As a group, the patients did exhibit significantly reduced HCO 3 − absorption in their test segment, but the interindividual variation was fairly large, with "normal" absorption values occurring in some subjects. The linear correlation between HCO 3 − absorption and luminal HCO 3 − concentration was also lost in the patients, which precluded "backward" calculation of the amount of HCO 3 − entering the mixing segment. Another puzzling finding was that, despite their inability to absorb HCO 3 − in the test segment, the patients had a HCO 3 − concentration at the proximal aspiration site that was virtually identical with that in the controls (table 1) . However, in the patients, the decrease in HCO 3 − concentration was almost exactly paralleled by dilution of the volume marker-that is, the mechanism was probably increased inflow of secreted fluid with a low HCO 3 − concentration into the mixing segment. 22 The reason for the much larger variability in the HCO 3 − transport data in the patients is not altogether clear. Prostaglandins, which are released during inflammation, stimulate HCO 3 − secretion also in the distal duodenum, 21 and it cannot therefore be excluded that a numerically relevant secretory HCO 3 − flux may have occurred in some of the villus atrophy patients. Other possibilities are interindividual diVerences in the degree of villus atrophy, or simply shortcomings of our fairly crude methodology. However, it should be stressed that, despite the relatively large scatter, HCO 3 − transport rate in the patient group was significantly diVerent from that in the healthy subjects.
In all three groups, the same solution was infused at the same rate and one therefore also expects diVerences in HCO 3 − absorption between the groups to be reflected by changes in luminal acidity and PCO 2 , particularly at the distal aspiration site. Since our hypothesis was
